Stanford HAI warns AI mental health regulation lacks definitions

Stanford HAI reported on August 7, 2026, that the absence of consensus distinguishing clinical AI from wellness features prevents coherent mental health technology regulation. The institute stated this definitional void forces companies to operate in legal ambiguity while regulators struggle to apply existing medical device frameworks to generative models. Without standardized classification criteria, oversight remains fragmented across jurisdictions, creating uneven safety standards for vulnerable users seeking psychological support. Stanford researchers emphasized that current policies fail to address the unique risks posed by conversational agents offering therapeutic advice without clinical validation. The report urges policymakers and industry stakeholders to establish clear functional boundaries before expanding market access. This regulatory gap reportedly enables non-clinical tools to make implicit health claims while avoiding FDA scrutiny applicable to diagnosed treatment software. Stakeholders warn prolonged uncertainty may delay beneficial innovations alongside unsafe products.